Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco DB Agriculture Fund (DBA) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

Invesco DB Agriculture FundTrade
Ginkgo Bioworks Holdings IncTrade

Price performance (Past 24H)

Key statistics

Invesco DB Agriculture Fund vs Ginkgo Bioworks Holdings Inc — how do they compare? Invesco DB Agriculture Fund trades at $28.35 (market cap $1.32B), while Ginkgo Bioworks Holdings Inc trades at $12.93 (market cap $763.64M). The key difference: Invesco DB Agriculture Fund is the larger of the two by market cap, and Invesco DB Agriculture Fund is more actively traded (771,657 versus 3,204,177). Which is the better fit depends on your goals — on Pluang, investors hold Invesco DB Agriculture Fund for 24 Days and Ginkgo Bioworks Holdings Inc for 7 Days on average.

DBADNA
Market Cap
$1.32B$763.64M
Volume
771,6573,204,177
52-Week High
$29.49$15.83
52-Week Low
$25.44$5.48
Typical Hold Time
24 Days7 Days
Sector
—Health
Enterprise Value
—$865.59M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco DB Agriculture Fund

DBA (Invesco DB Agriculture Fund ETF) trades at $28.295, down 0.68% today, with a bearish technical signal from moving averages but neutral oscillators. The ETF has delivered strong 12.4% YTD returns, outperforming the S&P 500 in recent months according to Zacks Investment Research (2026-07-30). Recent news highlights agricultural ETF strength driven by weather risks and geopolitical tensions, though the fund carries a relatively high 0.85% expense ratio.

The agricultural commodities exposure positions DBA for potential upside from supply chain disruptions and global demand, but investors face volatility risks from commodity price swings and geopolitical uncertainty. Analyst sentiment remains mixed with Seeking Alpha maintaining a Hold rating (2026-09-22) while noting bullish long-term trends since 2020.

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $13.04, up 13.69% in the last session, with a bullish technical signal from moving averages. The company maintains strong gross margins at 68.04% but faces significant losses with a -219.6% net income margin. Recent developments include a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnerships expanding genetic testing distribution.

While technical momentum appears positive, fundamental challenges persist with substantial cash burn and declining revenue projections. Analyst sentiment is divided equally between buy, hold, and sell ratings. Investment opportunity lies in the company's strategic partnerships and government contracts, balanced against ongoing profitability concerns and competitive pressures in biotech.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DBA
100% Buy0% Sell
Avg holding period · 24 Days
DNA
47% Buy53% Sell
Avg holding period · 7 Days

Top news

Latest headlines on both assets

About Invesco DB Agriculture Fund

The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.

Read more on DBA →

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →